Loading chart…
PRE-MARKET
Supriya Lifescience Limited engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals in India and internationally. The company offers active pharmaceuticals ingredients in antihistamine, anti-allergic, anti-asthmatic, decongestant, analgesic/anti-pyretic/anesthetic, antihypertensive, vitamins, anti-malarial, and anti-gout areas. It also provides finished formulation products.
Supriya Lifescience Limited (SUPRIYA) is listed on the NSE in the Healthcare sector, Biotechnology industry. The SUPRIYA share price is ₹650.95 (-25.04% today), with a market capitalisation of ₹52B and a price-to-earnings (P/E) ratio of 26.4. MarketRipple tracks the SUPRIYA investment thesis, the ripple-chain impact of market events on Supriya Lifescience Limited, and the Healthcare sector outlook.
Open
₹659.40
High
₹662.25
Low
₹637.00
Prev. Close
₹868.45
52W High
₹1,085.00
52W Low
₹545.50
Day range
₹637.00–₹662.25
52-week range
₹545.50–₹1,085.00
Volume
884K
P/E
26.4
ROE
17.5%
D/E
0.00
Margin
22.7%
Supriya Lifescience Limited (NSE: SUPRIYA) is currently trading at ₹650.95 (-25.04%).
Supriya Lifescience Limited's market capitalization is ₹52B.
Supriya Lifescience Limited's price-to-earnings (P/E) ratio is 26.4.
Supriya Lifescience Limited operates in the Healthcare sector (Biotechnology).
Analyst consensus on Supriya Lifescience Limited currently reads neutral, based on 2 analysts covering the stock. This is third-party analyst data, not a MarketRipple recommendation.